Needham Investment Management’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-175
| Closed | -$171K | – | 131 |
|
|
2021
Q4 | $171K | Sell |
175
-193
| -52% | -$189K | 0.02% | 117 |
|
|
2021
Q3 | $706K | Hold |
368
| – | – | 0.09% | 100 |
|
|
2021
Q2 | $978K | Hold |
368
| – | – | 0.14% | 87 |
|
|
2021
Q1 | $1.53M | Buy |
368
+68
| +23% | +$283K | 0.21% | 78 |
|
|
2020
Q4 | $1.72M | Buy |
+300
| New | +$1.72M | 0.29% | 74 |
|
|
2019
Q4 | – | Sell |
-28
| Closed | -$65K | – | 102 |
|
|
2019
Q3 | $65K | Sell |
28
-20
| -42% | -$46.4K | 0.02% | 85 |
|
|
2019
Q2 | $139K | Sell |
48
-32
| -40% | -$92.7K | 0.05% | 83 |
|
|
2019
Q1 | $242K | Buy |
80
+40
| +100% | +$121K | 0.08% | 77 |
|
|
2018
Q4 | $46K | Sell |
40
-75
| -65% | -$86.3K | 0.02% | 83 |
|
|
2018
Q3 | $85K | Sell |
115
-8
| -7% | -$5.91K | 0.03% | 85 |
|
|
2018
Q2 | $121K | Sell |
123
-91
| -43% | -$89.5K | 0.03% | 90 |
|
|
2018
Q1 | $1.1M | Buy |
214
+10
| +5% | +$51.4K | 0.31% | 57 |
|
|
2017
Q4 | $1.1M | Sell |
204
-48
| -19% | -$259K | 0.29% | 60 |
|
|
2017
Q3 | $2.25M | Buy |
252
+37
| +17% | +$330K | 0.57% | 50 |
|
|
2017
Q2 | $1.61M | Buy |
215
+102
| +90% | +$765K | 0.43% | 52 |
|
|
2017
Q1 | $725K | Buy |
113
+43
| +61% | +$276K | 0.19% | 72 |
|
|
2016
Q4 | $799K | Buy |
70
+47
| +204% | +$536K | 0.2% | 73 |
|
|
2016
Q3 | $314K | Buy |
+23
| New | +$314K | 0.08% | 82 |
|